JPRN-UMIN000002491Not yet recruitingPhase 2
Multicenter study about an effect of Vinorelbine for recurrent brteast cancer - Naberubine study
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •poor prognoses and poor PS
Investigators
Similar Trials
Active, not recruiting
Phase 1
A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclinesTreatment in metastatic breast cancer previously treated with anthracyclinesEUCTR2004-000963-81-BEPierre Fabre Medicament230
Active, not recruiting
Not Applicable
A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclinesTreatment in metastatic breast cancer previously treated with anthracyclinesEUCTR2004-000963-81-ATRobapharm AG230
Recruiting
Phase 2
Treatment of ectopic pregnancies of participants with vinorelbine tablets.Reproductive Health and Childbirth - Other reproductive health and childbirth disordersECTOPIC PREGNANCYACTRN12617001118392orth Shore Hospital20
Completed
Not Applicable
Randomised phase II trial comparing vinorelbine and capecitabine with docetaxel and capecitabine chemotherapy for metastatic breast cancerBreastCancerBreast cancerISRCTN66842537Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)100
Completed
Phase 2
Meinetenance chemotherapy in lung cancerMalignant neoplasm of lung and brochous.Malignant neoplasm of bronchus and lung including: main bronchus, upper lobe bronchus , Middle lobe bronchus, Lower lobe, bronchus or Bronchus or lung, unspecified.code:C34IRCT2015060822610N1Investigator100